Skip to content
Important: This site presents data from the FDA Adverse Event Reporting System (FAERS). A report does not mean the drug caused the event. Full disclaimer.

Compare Drugs in GLP-1 Receptor Agonist [EPC]

Boost Your Natural Energy & Metabolism

Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.

Try Mitolyn Now
Drug Reports Deaths Death Rate Hosp. Life-Threat. Avg Age % Female
TIRZEPATIDE 99,893 455 0.5% 5,527 718 53.9 yrs 75.6%
DULAGLUTIDE 74,022 1,054 1.4% 6,536 532 61.9 yrs 57.8%
SEMAGLUTIDE 59,604 792 1.3% 11,258 1,214 59.1 yrs 66.6%
EXENATIDE 31,297 1,228 3.9% 2,512 305 63.1 yrs 55.9%
LIRAGLUTIDE 23,119 994 4.3% 4,819 697 57.3 yrs 67.6%

Head-to-Head Comparisons

TIRZEPATIDE vs DULAGLUTIDE TIRZEPATIDE vs SEMAGLUTIDE TIRZEPATIDE vs EXENATIDE TIRZEPATIDE vs LIRAGLUTIDE DULAGLUTIDE vs SEMAGLUTIDE DULAGLUTIDE vs EXENATIDE DULAGLUTIDE vs LIRAGLUTIDE SEMAGLUTIDE vs EXENATIDE SEMAGLUTIDE vs LIRAGLUTIDE EXENATIDE vs LIRAGLUTIDE
← Back to GLP-1 Receptor Agonist [EPC] Class side effects →